Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram PK and ECG in elderly volunteers
NCT02122939Phase 1Completed
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of escitalopram in major depressive disorder (MDD) and generalized anxiety disorder (GAD), sponsored by Seoul National University Hospital. Primary endpoint: Pharmacokinetic parameters (Cmax, AUCinf, AUClast, Tmax, t1/2, CL/F) at 48 hours. Started Sep 2013; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT02122939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02122939.